Biomea Fusion, Inc. (BMEA)
1.345
+0.10
(+8.47%)
USD |
NASDAQ |
Jan 02, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Research and Development Expense (TTM): 79.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Humacyte, Inc. | 75.35M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |
| Oragenics, Inc. | 3.387M |